publication date: Feb. 22, 2019

Funding Opportunities

ASCO invites applications for research based on data from CancerLinQ Discovery

The American Society of Clinical Oncology is inviting applications for research grants for projects that use data from CancerLinQ Discovery, an offering of ASCO’s CancerLinQ initiative, as a source.

CancerLinQ Discovery provides curated sets of de-identified data from cancer patients to academic researchers, government agencies, and others in the oncology community to generate practical knowledge that will improve cancer care.

“These research support grants provide investigators with a unique opportunity to explore unseen patterns in patient characteristics and outcomes using real-world data from CancerLinQ Discovery,” ASCO Chief Medical Officer Richard Schilsky said in a statement. “The findings from their research have the potential to inform clinical practice and improve the quality of patient care.”

CancerLinQ collects and analyzes real-world data from patients at practices nationwide, drawing from electronic health records. The CancerLinQ Discovery de-identified custom data sets are derived from the vast pool of data contributed by participating practices.

With grants of $32,500 each, ASCO will provide early and mid-career clinical oncology and health service investigators with real-world evidence that can inform their research. The grants—as many meritorious awards as funds permit—are being funded by the Mission Endowment of Conquer Cancer, The ASCO Foundation. Each one-year grant covers the cost of the CancerLinQ Discovery data set and a kickoff meeting at ASCO headquarters and contributes to personnel and/or research expenses.

Applicants are invited to submit research proposals consistent with ASCO’s mission to conquer cancer through research, education, and promotion of the highest quality patient care that can be addressed using CancerLinQ Discovery data.

Research topics may include adoption of treatment guidelines across … Continue reading ASCO invites applications for research based on data from CancerLinQ Discovery

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2021 The Cancer Letter Inc.